Development and Characterization of Curcumin Loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effect on Breast Cancer Cells through RFC Gene Expression
Open Access
- 1 March 2025
- journal article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 26 (3) , 1017-1026
Abstract
Background: Breast cancer is the second leading cause of cancer deaths among women. Recent studies emphasize the significant role of folate metabolic pathways in cancer progression. The Reduced Folate Carrier (RFC), a folate transporter in cell membranes, plays an essential role in transporting folate receptor-dependent drugs. Curcumin, a bioactive compound with anticancer and anti-inflammatory effects, is hindered by low stability and a short half-life. Niosomes are versatile nanoparticles that can deliver both hydrophilic and hydrophobic drugs. Objective: This study aims to evaluate the anticancer effects of curcumin-loaded niosomal nanoparticles, focusing on their impact on RFC, BAX, and BCL-2 gene expression in MDA-MB-231 breast cancer cells. Methods: Curcumin-loaded noisomal nanoparticles were synthesized by the thin-film hydration method. Then, the morphology, size, and physico-chemical nanoparticles were determined by FE-SEM, DLS, and FT-IR methods, respectively. The MTT results determined the cytotoxicity of free and nano-formulated curcumin; also, the gene expression of RFC, BCL-2, and BAX was evaluated using the Real-Time PCR method. Furthermore, apoptosis and cell cycle analysis were investigated by Flow cytometry. Results: The results of the physicochemical characteristics of the nanoparticles showed that curcumin was appropriately loaded in niosomal NPs. The MTT results showed that curcumin loaded in niosomal NPs has a higher anti-proliferative effect than free curcumin. Real-time PCR results showed increased RFC and BAX gene expression and decreased BCL-2 gene expression; this change was more significant in the treatment with nano-formulated curcumin. The apoptosis and cell cycle analysis also confirmed that free and nano-formulated curcumin induces apoptosis and cell cycle arrest. Conclusion: Overall, the results suggested that curcumin loaded in niosomal nanoparticles effectively improves the anticancer effect and could be a capable approach for treating breast cancer.Keywords
This publication has 63 references indexed in Scilit:
- Hypersensitivity Reactions to Chemotherapeutic DrugsClinical Reviews in Allergy & Immunology, 2003
- MRI of the tumor microenvironmentJournal of Magnetic Resonance Imaging, 2002
- Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax inductionFEBS Letters, 2002
- Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer CellsJournal of Biological Chemistry, 2001
- Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.2001
- Down-Regulation of Reduced Folate Carrier Gene (RFC1) Expression after Exposure to Methotrexate in ZR-75-1 Breast Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Expression and Differential Polarization of the Reduced-folate Transporter-1 and the Folate Receptor α in Mammalian Retinal Pigment EpitheliumJournal of Biological Chemistry, 2000
- Molecular Mechanism of Antifolate Transport-Deficiency in a Methotrexate-Resistant MOLT-3 Human Leukemia Cell LineBlood, 1997
- The effect of prescribed daily dose frequency on patient medication complianceArchives of internal medicine (1960), 1990
- Antioxidant activity of curcumin and related compoundsBiochemical Pharmacology, 1976